1-5 of 5
Emil Hermansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Anna Lysén, Pegah Abdollahi, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2024-193864
Published: 2024
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysen, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 3381.
https://doi.org/10.1182/blood-2023-173126
Published: 2023
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Diana Schjøll, Anna Lysén, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2022) 140 (Supplement 1): 12623–12625.
https://doi.org/10.1182/blood-2022-156625
Published: 2022
Journal Articles

Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

Maria-Victoria Mateos, Paula Rodriguez Otero, Youngil Koh, Joaquin Martinez-Lopez, Gurdeep Parmar, H. Miles Prince, Hang Quach, Paz Ribas, Emil Hermansen, Vania T.M. Hungria, Sevgi Kalayoglu Besisik, Jin Seok Kim, Xavier Leleu, Valdas Pečeliūnas, Fredrik Schjesvold, Omur G. Sevindik, Tatiana Lavrova, Franck Dubin, Christine Devisme, Lucie Lepine, Sandrine Macé, Mony Morisse, Irene Ghobrial
Journal: Blood
Blood (2022) 140 (Supplement 1): 7317–7319.
https://doi.org/10.1182/blood-2022-157302
Published: 2022
Journal Articles

The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Noergaard Strandholdt, Mette Klarskov Andersen, Annette J. Vangsted
Journal: Blood
Blood (2021) 138 (Supplement 1): 3779.
https://doi.org/10.1182/blood-2021-152070
Published: 2021